- Home
- PWM vs ADXN Comparison
PWM vs ADXN Comparison
Compare PWM & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PWM
- ADXN
- Stock Information
- Founded
- PWM 2018
- ADXN 2002
- Country
- PWM Hong Kong
- ADXN Switzerland
- Employees
- PWM N/A
- ADXN N/A
- Industry
- PWM
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- PWM
- ADXN Health Care
- Exchange
- PWM Nasdaq
- ADXN Nasdaq
- Market Cap
- PWM 12.4M
- ADXN 10.1M
- IPO Year
- PWM 2023
- ADXN N/A
- Fundamental
- Price
- PWM $0.37
- ADXN $7.85
- Analyst Decision
- PWM
- ADXN Strong Buy
- Analyst Count
- PWM 0
- ADXN 1
- Target Price
- PWM N/A
- ADXN $30.00
- AVG Volume (30 Days)
- PWM 90.3K
- ADXN 1.5K
- Earning Date
- PWM 08-19-2025
- ADXN 08-19-2025
- Dividend Yield
- PWM N/A
- ADXN N/A
- EPS Growth
- PWM N/A
- ADXN N/A
- EPS
- PWM N/A
- ADXN 0.10
- Revenue
- PWM $639,912.00
- ADXN $278,508.00
- Revenue This Year
- PWM N/A
- ADXN $86.57
- Revenue Next Year
- PWM N/A
- ADXN N/A
- P/E Ratio
- PWM N/A
- ADXN $0.70
- Revenue Growth
- PWM 83.60
- ADXN N/A
- 52 Week Low
- PWM $0.31
- ADXN $6.51
- 52 Week High
- PWM $2.70
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- PWM 41.59
- ADXN 39.98
- Support Level
- PWM $0.37
- ADXN $8.01
- Resistance Level
- PWM $0.40
- ADXN $8.19
- Average True Range (ATR)
- PWM 0.03
- ADXN 0.07
- MACD
- PWM -0.01
- ADXN -0.02
- Stochastic Oscillator
- PWM 7.53
- ADXN 9.81
About PWM Prestige Wealth Inc.
Prestige Wealth Inc is engaged in providing private wealth management services and asset management to high-net-worth and ultra-high-net-worth individuals and enterprises through its subsidiaries.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.